Introduction
============

Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disorder due to *MEFV* mutations and one of the most frequent Mediterranean genetic diseases. The observation of many heterozygous patients in whom a second mutated allele was excluded led to propose that heterozygosity could be causal; however, this might often be coincidental due to the very high rate of mutations in Mediterranean populations.

Objectives
==========

To better delineate the pathogenicity of heterozygosity in order to help genetic counselling and better manage the disease.

Methods
=======

Complementary statistical approaches were used: estimation of FMF prevalence at population levels, genotype comparison in siblings from 63 familial forms, and genotype study in 557 patients from four Mediterranean populations.

Results
=======

At population level, we did not observe any contribution of heterozygosity to the disease prevalence. In affected siblings of patients carrying two *MEFV* mutations, 92% carry two mutated alleles whereas 4% are heterozygous with typical FMF diagnosis. We also demonstrated statistically that patients are more prone to be heterozygous than healthy individuals, as shown by the higher ratio heterozygous carriers/non carriers in patients (p\<10^-7^ - p\<0.003). The risk for heterozygotes to develop FMF was estimated between 2.1x10^-3^ and 5.8x10^-3^ and the relative risk, as compared to individuals carrying no *MEFV* mutation, between 6.3 and 8.1.

Conclusion
==========

This is the first statistical demonstration that heterozygosity is not responsible for classical Mendelian FMF, but constitutes a susceptibility factor for clinically-similar complex conditions. We also provide a first estimate of the risk for heterozygotes to develop FMF.
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